HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Metaphyseal Anadysplasia 1

Also Known As:

MANDP1

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Musculoskeletal Diseases: 719
- Bone Diseases: 5863
  - Developmental Bone Diseases: 153
    - Osteochondrodysplasias: 592
      - Metaphyseal Anadysplasia 1: 1
- Musculoskeletal Abnormalities: 43
  - Congenital Limb Deformities: 8
    - Metaphyseal Anadysplasia 1: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Congenital Abnormalities: 25723
  - Musculoskeletal Abnormalities: 43
    - Congenital Limb Deformities: 8
      - Metaphyseal Anadysplasia 1: 1
- Inborn Genetic Diseases: 11939
  - Osteochondrodysplasias: 592
    - Metaphyseal Anadysplasia 1: 1

Experts

1.	Chen, Lili: 1 article (11/2019)
2.	Hu, Xuyun: 1 article (11/2019)
3.	Li, Niu: 1 article (11/2019)
4.	Shen, Jun: 1 article (11/2019)
5.	Shi, Yu: 1 article (11/2019)
6.	Song, Cui: 1 article (11/2019)
7.	Xu, Xuejiao: 1 article (11/2019)
8.	Zhou, Ting: 1 article (11/2019)
9.	Zhu, Min: 1 article (11/2019)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Metaphyseal Anadysplasia 1:

1.	Matrix Metalloproteinase 13IBA 11/01/2019 - "Matrix metalloproteinase 13 encoded by MMP13 presumably plays important roles in bone formation and growth, and pathogenic variants in MMP13 have been identified to cause metaphyseal anadysplasia 1. Only six pathogenic variants in MMP13 have been previously reported worldwide. "